sH2a is derived from the H2 subunit of the human asialoglycoprotein receptor (ASGPR) and is a soluble secreted protein specifically expressed in the liver.

By detecting sH2a in the serum of patients, it can be used for the diagnosis and monitoring of liver damage caused by alcoholic hepatitis, non-alcoholic hepatitis, liver fibrosis, liver cirrhosis, and liver cancer.